In the Original Investigation titled “Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19,”1 published December 10, 2020, there was an error in the References section. The References section incorrectly listed the article by Arshad et al2 as reference 26. The correct reference is Boulware et al.3 This article has been corrected.1
References
- 1.Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open. 2020;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Arshad S, Kilgore P, Chaudhry ZS, et al. ; Henry Ford COVID-19 Task Force . Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. Int J Infect Dis. 2020;97:396-403. doi: 10.1016/j.ijid.2020.06.099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Boulware DR, Pullen MF, Bangdiwala AS, et al. . A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med. 2020;383(6):517-525. doi: 10.1056/NEJMoa2016638 [DOI] [PMC free article] [PubMed] [Google Scholar]